GRAIL, Inc. (GRAL) News
Track canonical SquawkNews coverage tagged to GRAL, GRAIL, Inc.. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 24 indexed stories across 14 publication days and is ordered by the same first-publication timeline used by LiveCast.
M
GRAIL shares jump after FDA briefing papers support Galleri review
GRAIL (GRAL) surged 34% on Monday to its best day since February 2025 after the FDA posted briefing papers indicating no particular concerns for Wednesday’s review of the Galleri blood test.
EQUITY | Sep 21, 2026, 08:50 PM UTC
M
Grail shares surge after FDA staff see no major test concerns
US FDA staff reviewers said they did not raise major concerns about the accuracy and safety of Grail’s multi-cancer blood test. Grail’s shares surged 35% on Monday.
EQUITY | Sep 21, 2026, 04:41 PM UTC
H
GRAIL Q2 2026 Earnings Call: Complete Transcript
On Wednesday, GRAIL (NASDAQ: GRAL ) discussed second-quarter financial results during its earnings call. The full transcript is provided below. This content is powered APIs. For comprehensive financial data and transcrip
LIVE | Sep 18, 2026, 06:55 AM UTC
L
Grail announces inducement grants under Nasdaq Rule 5635(c)(4)
Grail Inc said it will make inducement grants under Nasdaq Listing Rule 5635(c)(4).
EQUITY | Sep 03, 2026, 09:37 PM UTC
L
GRAIL announces inducement grants under NASDAQ Rule 5635(c)(4)
GRAIL said it is announcing inducement grants under NASDAQ listing rule 5635(c)(4).
EQUITY | Sep 03, 2026, 08:02 PM UTC
L
GRAL - GRAIL to Present at Morgan Stanley's 24th Annual Global Healthcare Conference
GRAL - GRAIL to Present at Morgan Stanley's 24th Annual Global Healthcare Conference
EQUITY | Aug 31, 2026, 08:01 PM UTC
L
GRAL - GRAIL Announces FDA Advisory Committee Meeting to Review Premarket Approval Application for the Galleri® Multi- Cancer Early Detectio
GRAL - GRAIL Announces FDA Advisory Committee Meeting to Review Premarket Approval Application for the Galleri® Multi- Cancer Early Detection Test
REGULATION | Aug 07, 2026, 03:05 PM UTC
H
GRAL Reports Q2 Revenue Up 26% YoY
GRAL Q2 revenue rises 26% to $44.7m
EQUITY | Aug 05, 2026, 08:17 PM UTC
L
GRAL GRAL - GRAIL Reports Second Quarter 2026 Financial Results
GRAL GRAL - GRAIL Reports Second Quarter 2026 Financial Results
EARNINGS | Aug 05, 2026, 08:03 PM UTC
L
GRAL - GRAIL, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - GRAL
GRAL - GRAIL, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - GRAL
EQUITY | Jul 31, 2026, 06:47 AM UTC
L
GRAL to Present at Conference
GRAL presents at growth conference
EQUITY | Jul 30, 2026, 08:02 PM UTC
L
Grail: Lead Plaintiff Deadline
Grail lawsuit lead plaintiff deadline
FX | Jul 30, 2026, 02:07 PM UTC
L
GRAL GRAL - GRAIL to Announce Second Quarter 2026 Financial Results
GRAL GRAL - GRAIL to Announce Second Quarter 2026 Financial Results
EARNINGS | Jul 29, 2026, 08:01 PM UTC
L
$GRAL Fraud Notification: GRAIL, Inc. Sued for Securities Fraud After Trial Results Spark a 50% Stock Drop – Investors Notified to Contact B
A securities fraud class action lawsuit has been filed on behalf of GRAIL investors after its stock plummet
REGULATION | Jul 06, 2026, 10:48 AM UTC
L
GRAL Investors Have Opportunity to Lead GRAIL, Inc. Securities Fraud Lawsuit
GRAL Investors Have Opportunity to Lead GRAIL, Inc. Sec
REGULATION | Jul 06, 2026, 10:44 AM UTC
L
GRAL Investor Alert: GRAIL, Inc. Investors Notified of the Important August 4 Deadline in Filed Securities Fraud Class Action Lawsuit
A securities fraud class action lawsuit has been filed on behalf of GRAIL investors after its stock plummeted 50% because GRAIL allegedly misled investors relating to GRAIL's NHS-Galleri cancer
REGULATION | Jul 05, 2026, 11:12 AM UTC
L
Pomerantz LLP Issues Reminder to Investors in GRAIL, Inc. of Class Action Filing – GRAL
NEW YORK CITY, NY / / July 4, 2026 / Pomerantz LLP announces that a class action lawsuit has been filed against
EQUITY | Jul 04, 2026, 10:00 PM UTC
L
$GRAL Stock Loss Notice: GRAIL, Inc. Investors That Lost Money When Stock Plummeted 50% May Have Rights in Securities Fraud Class Action
NEW YORK CITY, NY / / July 4, 2026 / Leading securities law firm
EQUITY | Jul 04, 2026, 10:18 AM UTC
L
GRAL Court Reminder: GRAIL, Inc. Investors are Notified to Act before the Upcoming Securities Fraud Class Action Deadline on August 4
A securities fraud class action lawsuit has been filed on behalf of GRAIL investors after its stock plummeted 50% because GRAIL allegedly misled investors relating to GRAIL's NHS-Galleri cancer
REGULATION | Jul 03, 2026, 07:18 PM UTC
L
GRAIL, Inc. (GRAL) Faces Securities Class Action Amid NHS-Galleri Trial Failure, $2.2B Market Cap Wipeout -- HBSS
SAN FRANCISCO, July 03, 2026 (GLOBE NEWSWIRE) -- On February 20, 2026, GRAIL, Inc. (NASDAQ: GRAL<
EQUITY | Jul 03, 2026, 06:18 PM UTC
L
GRAL Investors Have Opportunity to Lead GRAIL, Inc. Securities Fraud Lawsuit with the Schall Law Firm
LOS ANGELES, July 03, 2026 (GLOBE NEWSWIRE) -
REGULATION | Jul 03, 2026, 01:33 PM UTC
L
Pomerantz LLP Issues Reminder to Shareholders in GRAIL, Inc. of Class Action – GRAL
NEW YORK CITY, NY / / July 3, 2026 / Pomerantz LLP announces that a class action lawsuit has been filed against
EQUITY | Jul 03, 2026, 11:01 AM UTC
L
GRAL Shareholder News: GRAIL, Inc. Accused of Making Misrepresentations about its Trial Results in Securities Fraud Class Action – Investors
NEW YORK, July 03, 2026 (GLOBE NEWSWIRE) -- Leading securities law firm
EQUITY | Jul 03, 2026, 10:07 AM UTC
M
GRAL Raises $110M
GRAIL completes $110 million equity financing with Samsung entities
EQUITY | Jun 25, 2026, 01:01 PM UTC